Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Postoperative Adjuvant Treatment”

271 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 271 results

Not applicableEnded earlyNCT02526537
What this trial is testing

Gefitinib for EGFR Sensitive Mutation Postoperative Stage Ib NSCLC Patients

Who this might be right for
NSCLC
Lunxu Liu 10
Not applicableActive Not RecruitingNCT03239626
What this trial is testing

Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer

Who this might be right for
Cervix CancerRadiotherapy, AdjuvantRadiotherapy, Intensity-Modulated+1 more
Samsung Medical Center 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353476
What this trial is testing

Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLC

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)Post Surgical
Shanghai Zhongshan Hospital 38
Large-scale testing (Phase 3)Study completedNCT02586025
What this trial is testing

Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer to Evaluate Treatment With Trastuzumab Plus (+) Pertuzumab + Docetaxel Compared With Trastuzumab + Placebo + Docetaxel

Who this might be right for
Breast Cancer
Hoffmann-La Roche 329
Not applicableUnknownNCT01033578
What this trial is testing

Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma
Fudan University 260
Not applicableActive Not RecruitingNCT02456389
What this trial is testing

Perioperative Risk Study

Who this might be right for
TumorsPrimary NeoplasmSecondary Neoplasm+1 more
Fox Chase Cancer Center 1,456
Testing effectiveness (Phase 2)Looking for participantsNCT05825443
What this trial is testing

Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients

Who this might be right for
ImmunotherapyChemotherapy
Nanfang Hospital, Southern Medical University 57
Not applicableLooking for participantsNCT06581315
What this trial is testing

Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaAdjuvant Therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 204
Large-scale testing (Phase 3)Active Not RecruitingNCT03576417
What this trial is testing

A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Groupe Oncologie Radiotherapie Tete et Cou 680
Large-scale testing (Phase 3)Looking for participantsNCT07034326
What this trial is testing

Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerElectroacupunctureImmune Checkpoint Inhibitors
Kong Fanming 405
Not applicableLooking for participantsNCT07417800
What this trial is testing

Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning

Who this might be right for
Hepatocellular Carcinoma (HCC)Artificial IntelligentAdjuvant Chemoradiotherapy+3 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 11,000
Testing effectiveness (Phase 2)Looking for participantsNCT06348134
What this trial is testing

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

Who this might be right for
Human Epidermal Growth Factor 2 Negative Carcinoma of BreastHER2-positive Breast CancerBreast Cancer
University of Chicago 74
Not applicableStudy completedNCT07562763
What this trial is testing

Estimation and Prediction of Individual Benefit From Postoperative Adjuvant Transcatheter Arterial Chemoembolization For Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)Transarterial ChemoembolizationAdjuvant Therapy+2 more
Anhui Provincial Hospital 1,005
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06987123
What this trial is testing

TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 62
Not applicableStudy completedNCT02724345
What this trial is testing

Postoperative Adjuvant TACE Treatment in CK18 Positive Patients

Who this might be right for
Postoperative Adjuvant TACEHepatocellular Carcinoma.
Eastern Hepatobiliary Surgery Hospital 320
Large-scale testing (Phase 3)Active Not RecruitingNCT05180734
What this trial is testing

PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer

Who this might be right for
Gastric or Esophagogastric Junction Adenocarcinoma
Shanghai Junshi Bioscience Co., Ltd. 878
Not applicableLooking for participantsNCT07180901
What this trial is testing

Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer

Who this might be right for
Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity CancerHead &Amp;Amp; Neck Squamous Cell CarcinomaLarynx Squamous Cell Carcinoma
Centre hospitalier de l'Université de Montréal (CHUM) 85
Not applicableStudy completedNCT07542782
What this trial is testing

Pancreatic Resection in Fit Octogenarians With Nonmetastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Medizinische Hochschule Brandenburg Theodor Fontane 2,048
Post-approval studies (Phase 4)Looking for participantsNCT06561620
What this trial is testing

Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients

Who this might be right for
3-year Disease-free Survival
Fudan University 592
Not applicableStudy completedNCT03239613
What this trial is testing

Postoperative Hypofractionated Intensity-modulated Radiation Therapy with Concurrent Chemotherapy in Cervical Cancer

Who this might be right for
Cervix CancerRadiotherapy, AdjuvantRadiotherapy, Intensity-Modulated+2 more
Samsung Medical Center 84
Next Page